Gilenya® Demonstrates Consistent Benefits..........

Gilenya, or Fingolimod, is the first approved oral disease modifying drug for MS.

Gilenya® Demonstrates Consistent Benefits..........

Postby MSUK » Tue Mar 26, 2013 12:30 am

Gilenya® Demonstrates Consistent Benefits In Reduction Of Relapses And Brain Volume Loss In Relapsing-Remitting MS

Data presented at the 65th annual meeting of the American Academy of Neurology (AAN) show Gilenya® (fingolimod), the first and only once-daily oral therapy reimbursed to treat highly active relapsing-remitting multiple sclerosis (RRMS), significantly and consistently reduced the rate of brain volume loss and reduced relapse rates compared to interferon beta-1a IM or placebo.

The new data add to the growing body of evidence for fingolimod regarding its early efficacy benefits and long-term safety profile..........Read More - http://www.ms-uk.org/index.cfm/gilenya
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2180
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to Gilenya

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service